Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic versus ultrasound-guided local betamethasone for rheumatoid arthritis tenosynovitis
2013-003486-34Phase 4Completed
- Sponsor
- Knowledge Centre for Rheumatology and Back Diseases
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone in rheumatoid arthritis (RA) and tendovaginitis (2 arms), sponsored by Knowledge Centre for Rheumatology and Back Diseases. Primary endpoint: Ultrasound tenosynovitis score response at 4 weeks. Started Nov 2013; status: completed.
02
Drugs
betamethasone
03
Conditions
rheumatoid arthritis (RA)tendovaginitis
Beyond the preview
Go deeper on 2013-003486-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003486-34.